Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 23, 2018Journal of Cardiovascular Development and DiseaseOpen Access

Apolipoprotein E and Atherosclerosis: From Lipoprotein Metabolism to MicroRNA Control of Inflammation

View Full Paper
Ask AI
Bookmark
Share

Authors

LBLaura BouchareychasRRRobert L. Raffaı̈

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bouchareychas et al. (2018) studied this question.

synapsesocial.com/papers/6a173238eae9613b5fbde6f2https://doi.org/10.3390/jcdd5020030
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Systemic Delivery of MicroRNA-181b Inhibits Nuclear Factor-κB Activation, Vascular Inflammation, and Atherosclerosis in Apolipoprotein E–Deficient Mice2013 · 288 citations
  2. 2Apolipoprotein E and atherosclerosis2000 · 250 citations
  3. 3Identification of a Novel Macrophage Phenotype That Develops in Response to Atherogenic Phospholipids via Nrf22010 · 566 citations
  4. 4Role of HDL, ABCA1, and ABCG1 Transporters in Cholesterol Efflux and Immune Responses2009 · 670 citations
  5. 5Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In.1986 · 147 citations